Paricalcitol Improves the Angiopoietin/Tie-2 and VEGF/VEGFR2 Signaling Pathways in Adriamycin-Induced Nephropathy.

导出 OA

翻译打印收藏纠错

第一作者： Amanda Lima,Deluque

第一单位： Laboratory of Renal Physiology, Department of Physiology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto 14040-900, SP, Brazil.

作者： Amanda Lima,Deluque ^[1] ; Beatriz Magalhães,Oliveira ^[1] ; Cláudia Silva,Souza ^[1] ; Ana Lívia Dias,Maciel ^[1] ; Heloísa Della Coletta,Francescato ^[1] ; Cleonice,Giovanini ^[1] ; Lucas Ferreira,de Almeida ^[1] ; Francisco José Albuquerque,de Paula ^[2] ; Roberto Silva,Costa ^[3] ; José,Antunes-Rodrigues ^[4] ; Terezila Machado,Coimbra ^[1]

作者单位： Laboratory of Renal Physiology, Department of Physiology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto 14040-900, SP, Brazil. ^[1] Laboratory of Endocrinology, Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto 14015-010, SP, Brazil. ^[2] Laboratory of Renal Pathology, Division of Nephrology, Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto 14015-010, SP, Brazil. ^[3] Laboratory of Neuroendocrinology, Department of Physiology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto 14040-900, SP, Brazil. ^[4]

关键词 Tie-2 receptor angiogenic factors angiopoietin-2 cell differentiation endothelial toxicity paricalcitol progressive kidney disease